PubMed · 17006823
The decrease in healthcare-associated methicillin-resistant Staphylococcus aureus infections and savings from glycopeptide use.
Abstract
We evaluated changes in the rate of healthcare-associated methicillin-resistant Staphylococcus aureus (MRSA) infections and healthcare-associated S. aureus infections after implementation of infection control precautions and the effect of this on glycopeptide use and expenditures for glycopeptides in a private medical center in Turkey in the years 2000-2005. A striking decrease was obtained in the number of MRSA infections, and the expenditure for glycopeptide use also decreased.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Diler Coskun, Jale Aytac. 2006-09-20. The decrease in healthcare-associated methicillin-resistant Staphylococcus aureus infections and savings from glycopeptide use.. https://doi.org/10.1086/507969
Cite the original work for its findings. Save a collection to share your selection of sources.